165 related articles for article (PubMed ID: 16249777)
21. Use of medical technologies in rehabilitation medicine settings in Israel: results of the TECHNO-R 2005 survey.
Ring H; Keren O; Zwecker M; Dynia A
Isr Med Assoc J; 2007 Oct; 9(10):713-6. PubMed ID: 17987758
[TBL] [Abstract][Full Text] [Related]
22. Action plan of the Professional Practice Committee-UEMS Physical and Rehabilitation Medicine Section: description and development of our field of competence.
Gutenbrunner A; Delarque A
Eur J Phys Rehabil Med; 2009 Jun; 45(2):275-80. PubMed ID: 19202530
[No Abstract] [Full Text] [Related]
23. Re: The practice of physical medicine and rehabilitation in subSaharan Africa and Antarctica: a white paper.
Campbell C
PM R; 2009 Nov; 1(11):1048. PubMed ID: 19942194
[No Abstract] [Full Text] [Related]
24. Response to Letter to the editor: New clinical end points in rehabilitation medicine: tools for measuring quality of life.
Rose M
Am J Hosp Palliat Care; 2010 Aug; 27(5):358; author reply 359. PubMed ID: 20338981
[No Abstract] [Full Text] [Related]
25. More than a cosmetic fix. Combined with physical therapy, botulinum toxin type A can help provide relief for chronic muscle pain.
Silberstein N
Rehab Manag; 2007; 20(1):44, 46. PubMed ID: 17310899
[No Abstract] [Full Text] [Related]
26. Botulinum toxin and neuromotor rehabilitation: An integrated approach to idiopathic cervical dystonia.
Tassorelli C; Mancini F; Balloni L; Pacchetti C; Sandrini G; Nappi G; Martignoni E
Mov Disord; 2006 Dec; 21(12):2240-3. PubMed ID: 17029278
[TBL] [Abstract][Full Text] [Related]
27. Physical medicine and rehabilitation in the 21st century.
Reinstein L
Arch Phys Med Rehabil; 1994 Jan; 75(1):1-2. PubMed ID: 8291948
[TBL] [Abstract][Full Text] [Related]
28. Action plan of the Physical and Rehabilitation Medicine Board.
Viton JM; Franchignoni F; Vanderstraeten G; Michail X; Delarque A
Eur J Phys Rehabil Med; 2009 Jun; 45(2):271-4. PubMed ID: 19209133
[No Abstract] [Full Text] [Related]
29. [Botulinum toxin: a new dimension for spasticity].
Reichel G
MMW Fortschr Med; 2007 May; 149 Suppl 2():65-9. PubMed ID: 17724971
[TBL] [Abstract][Full Text] [Related]
30. Development and validation of the vocal tremor scoring system.
Bové M; Daamen N; Rosen C; Wang CC; Sulica L; Gartner-Schmidt J
Laryngoscope; 2006 Sep; 116(9):1662-7. PubMed ID: 16955000
[TBL] [Abstract][Full Text] [Related]
31. Botulinum toxin type A in chronic migraine.
Freitag FG
Expert Rev Neurother; 2007 May; 7(5):463-70. PubMed ID: 17492897
[TBL] [Abstract][Full Text] [Related]
32. Novel opportunities in the treatment and prevention of scarring.
Berman B; Villa AM; Ramirez CC
J Cutan Med Surg; 2004; 8 Suppl 3():32-6. PubMed ID: 15647858
[TBL] [Abstract][Full Text] [Related]
33. A new vision for the study of benign prostate disease: the NIDDK Prostate Research Strategic Plan.
Mullins C; Kaplan SA
J Urol; 2009 Mar; 181(3):963-71. PubMed ID: 19150562
[TBL] [Abstract][Full Text] [Related]
34. Is rehab in trouble?
Smith R
Rehab Manag; 1999; 12(6):24-8, 116. PubMed ID: 10788186
[No Abstract] [Full Text] [Related]
35. A strategic plan for integrating cost-effectiveness analysis into the US healthcare system.
Neumann PJ; Palmer JA; Daniels N; Quigley K; Gold MR; Chao S;
Am J Manag Care; 2008 Apr; 14(4):185-8. PubMed ID: 18402510
[TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness of sacral neuromodulation versus intravesical botulinum A toxin for treatment of refractory urge incontinence.
Siddiqui NY; Amundsen CL; Visco AG; Myers ER; Wu JM
J Urol; 2009 Dec; 182(6):2799-804. PubMed ID: 19837427
[TBL] [Abstract][Full Text] [Related]
37. Developing research capacity in human functioning and rehabilitation research from the comprehensive perspective based on the ICF-model.
Stucki G; Reinhardt JD; Grimby G; Melvin J
Eur J Phys Rehabil Med; 2008 Sep; 44(3):343-51. PubMed ID: 18762743
[TBL] [Abstract][Full Text] [Related]
38. Logistics of companion animal rehabilitation.
Marcellin-Little DJ; Danoff K; Taylor R; Adamson C
Vet Clin North Am Small Anim Pract; 2005 Nov; 35(6):1473-84, x. PubMed ID: 16260323
[TBL] [Abstract][Full Text] [Related]
39. The action plan of the UEMS Physical and Rehabilitation Medicine Section and Board 2008-2010.
Delarque A; Michail X; Christodoulou N
Eur J Phys Rehabil Med; 2009 Jun; 45(2):265-70. PubMed ID: 19212302
[No Abstract] [Full Text] [Related]
40. How to anticipate the assessment of the public health benefit of new medicines?
Massol J; Puech A; Boissel JP;
Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
